Surge in Put Option Volumes and Open Interest
On 22 May 2026, Max Healthcare (NSE: MAXHEALTH) recorded substantial put option activity concentrated around strike prices close to its underlying value of ₹1,019.80. The most actively traded put options expiring on 26 May 2026 include strikes at ₹1,000, ₹1,010, ₹1,020, and ₹1,030. Among these, the ₹1,000 strike saw the highest number of contracts traded at 6,461, generating a turnover of approximately ₹303.59 lakhs and an open interest of 962 contracts.
Close behind, the ₹1,020 strike price put options traded 4,152 contracts with a turnover of ₹345.50 lakhs and open interest of 447 contracts. The ₹1,010 strike also attracted heavy volumes with 3,880 contracts traded, turnover of ₹278.87 lakhs, and open interest of 612 contracts. The ₹1,030 strike, slightly out-of-the-money, saw 2,969 contracts traded, turnover of ₹275.11 lakhs, and open interest of 340 contracts.
This clustering of put option activity near and just below the current stock price indicates a pronounced bearish stance or protective hedging by market participants anticipating potential downside risks in the near term.
Stock Performance and Technical Context
Max Healthcare’s stock price has declined sharply by 6.24% on the day, underperforming its hospital sector peers by 6.39% and contrasting with the broader Sensex’s modest gain of 0.34%. The stock opened with a gap down of 2.09% and touched an intraday low of ₹1,011.30, marking a 7.31% drop from previous levels. Notably, this decline follows a seven-day streak of consecutive gains, signalling a potential trend reversal.
Technical indicators reveal a mixed picture. The stock currently trades above its 50-day moving average but remains below its 5-day, 20-day, 100-day, and 200-day moving averages, suggesting short-term weakness amid longer-term support. The weighted average price for the day was closer to the intraday low, reflecting heavier volume traded near the lower price range and reinforcing bearish momentum.
Investor participation has risen, with delivery volumes on 21 May reaching 16.78 lakh shares, a 52.33% increase over the five-day average. This heightened activity, combined with the stock’s liquidity supporting trades worth approximately ₹4.54 crore based on 2% of the five-day average traded value, underscores active repositioning by market participants.
Mojo Score and Analyst Sentiment
Max Healthcare’s current Mojo Score stands at 42.0, categorised as a Sell rating. This represents a downgrade from a previous Hold rating as of 31 October 2025, reflecting deteriorating fundamentals or market outlook. The company remains a large-cap player in the hospital sector with a market capitalisation of ₹1,06,234 crore, but recent price action and option market data suggest investors are increasingly cautious.
Implications of Put Option Activity
The concentration of put option contracts near the stock’s current price level and the high open interest indicate that investors are either hedging existing long positions or speculating on further downside. The expiry date of 26 May 2026 is imminent, which may lead to increased volatility as traders adjust positions ahead of expiry.
Put options at strikes ₹1,000 and ₹1,010 are particularly significant as they are slightly out-of-the-money and represent key support levels. The large open interest at these strikes suggests that a breach below ₹1,000 could trigger further downside pressure, potentially accelerating the stock’s decline.
Sector and Market Comparison
Within the hospital sector, Max Healthcare’s underperformance is notable. While the sector declined by 0.76% on the day, Max Healthcare’s 6.24% drop highlights company-specific concerns or profit-taking. The broader market’s positive return contrasts with the stock’s weakness, emphasising the bearish sentiment concentrated on this name.
Investors should monitor upcoming corporate developments, earnings announcements, or sector news that could influence sentiment. The current option market positioning suggests that downside risks are being actively priced in, and any positive catalyst could trigger short-covering and a rebound.
Conclusion: Cautious Outlook for Max Healthcare
Max Healthcare Institute Ltd is currently navigating a challenging phase marked by heavy put option activity, technical weakness, and a recent downgrade in analyst sentiment. The significant volumes and open interest in put options near the stock price reflect a cautious or bearish outlook among investors, who appear to be hedging against potential declines or positioning for downside moves ahead of the 26 May expiry.
While the company’s large-cap status and sector presence provide some stability, the immediate technical signals and option market data warrant close attention. Investors should weigh these factors carefully and consider risk management strategies in light of the evolving market dynamics surrounding Max Healthcare.
